New Look Laser College Offers Additional Laser Tattoo Removal Training Course in Miami, Florida

Miami, Florida, March 15, 2021 (GLOBE NEWSWIRE) — New Look Laser College (NLLC), the national training division of Astanza Laser and leading tattoo removal training program, is hosting an additional tattoo removal training course in Miami, Florida on July 16 and 17, 2021. New Look Laser College was founded in 2007 and is the first training program in the world that certifies students exclusively on laser tattoo removal and Q-switched laser training.

New Look Laser College has trained thousands of students from various professions and backgrounds on how to safely perform laser tattoo removal and operate an aesthetic laser business using advanced Q-switched laser technology. Numerous laser practitioners, physicians, medical professionals, tattoo artists, and entrepreneurs who have attended New Look Laser College now run thriving tattoo removal businesses worldwide. New Look Laser College hosts 11 courses every year in several locations around the nation including Miami, Orlando, New York City, Las Vegas, and its headquarters in Dallas, TX.

After selling out the April 30th to May 1st Miami course and receiving a high demand for more training opportunities, New Look Laser College added a second Miami course to its 2021 summer schedule to accommodate the increased interest in laser tattoo removal training in Miami. This additional two-day laser tattoo removal course will take place on Friday and Saturday, July 16-17, 2021.

“We’re thrilled to see the interest in laser tattoo removal grow in Florida, and love coming to Miami to teach aspiring entrepreneurs and job-seekers alike,” said Justin Arnosky, Astanza Laser VP of Clinical Education and New Look Laser College department head. “It quickly became apparent that one course in Miami wasn’t enough, so we added another!”

Each New Look Laser College course is designed to prepare students to safely and properly perform laser tattoo removal treatments and, ultimately, start their own tattoo removal business. Courses are held over a two-day period that covers a wide range of educational topics including laser safety and compliance, laser physics, laser and skin interaction, laser protocols, assessing and treatment tattoos, patient consultation, aftercare and side effects, and an in-depth marketing and business operations section. Attendees also receive extensive hands-on treatment practice on a diverse pool of patients using the leading Astanza Q-switched laser technology, the Duality.

Graduates of New Look Laser College receive the designations of Certified Laser Specialist (CLS) and Laser Safety Officer (LSO) as well as an Advanced Laser Tattoo Removal Certification. Click here to register for the July Miami course. Students can save $300 when they take advantage of the early registration pricing and book the course by May 16, 2021. Click here to view the full 2021 course schedule and register for a New Look Laser College course. For all other inquiries, email [email protected] or call/text (281) 846-5890.

About Astanza Laser 

Astanza is the leader in lasers for tattoo removal, hair removal, and additional aesthetic procedures. In addition to delivering cutting-edge medical laser devices such as the Duality, Trinity, MeDioStar, and DermaBlate systems, Astanza offers its customers a complete range of training, marketing, and business consulting services to achieve success in this growing field. Astanza is an award-winning company that has received several accolades from leading industry organizations, including MyFaceMyBody and Aesthetic Everything. They are also certified as a “Great Place to Work”.

Astanza Laser is headquartered in Dallas, TX, with customers throughout North America and Europe. For product, investor, or press information, call (800) 364-9010, or visit https://astanzalaser.com/.



Astanza Laser
Astanza Laser
(800) 364-9010
[email protected]

Cyclacel to Present at the Oppenheimer 31st Annual Healthcare Conference

BERKELEY HEIGHTS, N.J., March 15, 2021 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that the Company will present at the Oppenheimer 31st Annual Healthcare Conference, a virtual event, on Thursday, March 18, 2021 at 9:20 AM (EDT). Spiro Rombotis, President & Chief Executive Officer, will provide an overview of the Company and progress in key programs. Cyclacel will host one-on-one meetings with investors during the event.

A live webcast of the presentation will be available through the Company’s website: www.cyclacel.com. The webcast will be archived for 90 days.

About Cyclacel Pharmaceuticals, Inc.

Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, and the anti-mitotic program CYC140, a PLK1 inhibitor, in patients with both solid tumors and hematological malignancies. Cyclacel’s strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit www.cyclacel.com

Forward-looking Statements

This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding, among other things, the efficacy, safety and intended utilization of Cyclacel’s product candidates, the conduct and results of future clinical trials, plans regarding regulatory filings, future research and clinical trials and plans regarding partnering activities. Factors that may cause actual results to differ materially include the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, trials may have difficulty enrolling, Cyclacel may not obtain approval to market its product candidates, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborative partners for further clinical trials, development and commercialization of product candidates. You are urged to consider statements that include the words “may,” “will,” “would,” “could,” “should,” “believes,” “estimates,” “projects,” “potential,” “expects,” “plans,” “anticipates,” “intends,” “continues,” “forecast,” “designed,” “goal,” or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties the Company faces, please refer to our most recent Annual Report on Form 10-K and other periodic and other filings we file with the Securities and Exchange Commission and are available at www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts
 
Company: Paul McBarron, (908) 517-7330, [email protected] 
Investor Relations: Russo Partners LLC, Jason Assad, (212) 845-4253, [email protected] 

© Copyright 2021 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc.



ProStar Hires Jason Martschuk as New VP of Sales for Canada

PR Newswire

GRAND JUNCTION, Colo., March 15, 2021 /PRNewswire/ — ProStar Holdings Inc. (“ProStar” or the “Company”) (TSXV: MAPS) (FSE: 5D00), a world leader in Precision Mapping Solutions™ is pleased to announce the Company has hired Jason Martschuk as the Company’s Vice President of Sales for Canada. Mr. Martschuk will be responsible for overseeing the sales of ProStar’s patented flagship mobile software application PointMan® for all of Canada. Mr. Martschuk’s responsibilities will be to utilize his extensive experience in sales, engineering, and geospatial technology to increase ProStar’s market awareness and footprint in Canada.

ProStar CEO and Founder Page Tucker commented, “We have strategically expanded both our sales and marketing teams so that we can start to expand our market penetration into Canada and abroad. Jason’s depth of experience as a seasoned sales executive in selling enterprise SaaS solutions combined with his expertise in geospatial technology and project management is a rare and very impressive combination. In addition, his experience with working for AMEC, Hexagon PPM, and most recently with Oracle makes him an incredibly valuable resource and I have no doubt his contribution will be immediate and measurable.”  

Jason Martschuk brings over 20 years of sales, GIS, and project management experience to ProStar Canada. As Executive Management for Oracle’s Construction and Engineering Global Business Unit for Western Canada, a Senior Sales Executive with Hexagon PPM, and as a GIS Specialist and Project Manager with AMEC.

“I look forward to expanding ProStar’s operations and increasing market share into Canada,” said Jason Martschuk. “When I first saw PointMan, I knew immediately that I was witnessing a technology that would forever change the industry and my career. I have been waiting for somebody to produce something like this for over 20 years, and now ProStar has done it. I am delighted to find a company that shares my vision and principles and provides such an incredible opportunity for me and my family.”

What You Should Know About ProStar (TSXV: MAPS) (FSE: 5D00)

ProStar is a world leader in Precision Mapping Solutions™. ProStar’s flagship product, PointMan, is natively cloud and mobile, and offered as a SaaS recurring revenue model. ProStar’s solutions are adopted by some of the largest entities in North America, including Fortune 500 construction firms, the largest subsurface utilities engineering (SUE) firms, and government agencies.

ProStar has strategic partnerships with the leading GPS/GNSS and cable and pipe locator manufactures as well as their dealer networks, including Trimble®, Vivax-Metrotech, Radiodetection®, and Subsite® Electronics.

The Company has made a significant investment in creating a vast intellectual property portfolio that includes 19 issued patents in the United States and Canada, with several more pending. The patents protect the methods required to digitally capture, record, and display the precise location of buried utilities and pipelines.

ProStar’s Executive management team has extensive experience in both early stage and Fortune 500 companies, TSX and TSX.V listed enterprises, and in geospatial, cloud and mobile technologies. ProStar’s leadership team includes Vasa Dasan, former CTO of Sun Microsystems, Carl Lashua, previous Chief Information Officer of HSBC Canada and Europe, and Matthew Breman prior Executive for Disneyworld Resorts.

For more information about ProStar, please visit: www.prostarcorp.com

Contact
Alex Moore 
Investor Relations Support 
[email protected]   
970-242-4024

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

This press release contains forward-looking information within the meaning of Canadian securities laws. Such information includes, without limitation, information regarding the terms and conditions of the Company’s future plans. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward-looking information is typically identified by words such as: “believe”, “expect”, “anticipate”, “intend”, “estimate”, “postulate” and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company is not a guarantee of future results or performance, and that actual results may differ materially from those in forward-looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s securities; the state of the technology sector; recent market volatility; the COVID-19 pandemic; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; and other risks and factors that the Company is unaware of at this time. The reader is referred to the Company’s recent Information Circular filed on SEDAR on November 20, 2020 for a more complete discussion of applicable risk factors and their potential effects, copies of which may be accessed through the Company’s issuer page on SEDAR at www.sedar.com.

The forward-looking statements contained in this press release are made as of the date of this press release. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/prostar-hires-jason-martschuk-as-new-vp-of-sales-for-canada-301246963.html

SOURCE ProStar Corp

InterRent REIT Results for the Fourth Quarter and 2020 Results

InterRent REIT Results for the Fourth Quarter and 2020 Results

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

OTTAWA, Ontario–(BUSINESS WIRE)–
InterRent Real Estate Investment Trust (TSX-IIP.UN) (“InterRent” or the “REIT”) today reported financial results for the fourth quarter and year-ended December 31, 2020.

Highlights

  • Operating revenues for the quarter ended December 31, 2020, increased by 6.8%, or $2.7 million, to $41.9 million. Operating revenues for the year increased by 10.1%, or $14.7 million, to $160.0 million.
  • Operating revenues for the quarter ended December 31, 2020 from the same property portfolio decreased by 1.5%, or $0.5 million, to $34.9 million. Operating revenues from the same property portfolio for the year increased by 3.1%, or $4.2 million, to $141.0 million.
  • Average monthly rent per suite for the portfolio increased to $1,315 (December 2020) from $1,260 (December 2019), an increase of 4.4%. Average monthly rent from the same property portfolio increased by 5.3% to $1,354 per suite (December 2020) from $1,286 per suite (December 2019).
  • Occupancy for the overall portfolio was 91.3%, down 430 basis points (December 2020 compared to December 2019). Occupancy for the same property portfolio was 92.4%, down 430 basis points (December 2020 compared to December 2019).
  • Net Operating Income (NOI) for the quarter ended December 31, 2020 increased by $0.2 million, or 0.6%, to $26.4 million. NOI margin for the quarter ended December 31, 2020 was 63.0%, a decrease of 390 basis points over the same period in 2019. NOI for the year increased by $5.9 million, or 6.2%, to $102.1 million. NOI margin for the year was 63.9%, a decrease of 230 basis points year-over-year. NOI for the year included $1.9 million of COVID-19 related operating expenses.
  • Same property NOI for the quarter ended December 31, 2020 decreased by $1.5 million, or 6.3%, to $22.4 million. Same property NOI margin for the quarter was 64.1%, a decrease of 330 basis points over the same period in 2019. Same property NOI for the year ended 2020 increased by $0.6 million, or 0.7%, to $91.3 million. Same property NOI margin for the full year was down 160 basis points year-over-year to 64.7%. Same Property NOI for the year included $1.6 million of COVID-19 related operating expenses.
  • Repositioned properties had an average monthly rent per suite of $1,371 and occupancy of 93.5% for December 2020 and an NOI margin of 64.7% for the quarter and 65.4% for the year.
  • Net income for the year was $150.6 million, a decrease of $234.2 million compared to 2019. The decrease was driven primarily by the net decrease in fair value gain on investment properties of $283.1 million ($70.1 million in 2020 compared to $353.2 million in 2019) offset by the higher non-cash fair value gains on unit-based liabilities and Class B unit liability from the Unit price depreciation in the year.
  • Funds from Operations (FFO) increased by $0.2 million, or 1.5%, for the quarter and increased $6.2 million, or 10.9% for the year.
  • Fully diluted FFO per unit was $0.112 for the quarter, a decrease of 11.1% over Q4 2019, and $0.466 for the year, a decrease of 3.5% over 2019.
  • Adjusted Funds from Operations (AFFO) increased by $0.3 million, or 1.8%, for the quarter and increased $5.3 million, or 10.5% for the year.
  • Fully diluted AFFO per unit was $0.100 for the quarter, a decrease of 9.9% over Q4 2019, and $0.412 for the year, a decrease of 3.7% over 2019.
  • Adjusted Cash Flow from Operations (ACFO) for the quarter increased by 6.0% to $20.2 million compared to Q4 2019. ACFO for the year increased by 2.8% to $62.8 million compared to 2019.
  • Debt-to-GBV ratio at year end was 31.1%, a decrease of 140 basis points from December 2019.
  • The weighted average interest rate on mortgage debt decreased from 3.02%, at December 31, 2019, to 2.56%, at December 31, 2020. Over the same period, the weighted average life to maturity has increased from 5.1 years to 5.2 years and mortgage debt backed by CMHC insurance has increased from 79% to 81%. Exposure to variable interest rate debt has decreased from approximately 12% (December 2019) to approximately 2% (December 2020).
  • 2020 was another active year for the REIT, acquiring a total of 880 rental suites and a further 14.17% direct ownership interest in the development site at 900 Albert Street (the Trust now holds a 47.5% interest in the development property) for $232.5 million.
  • Subsequent to the year end, the REIT purchased one building with 114 suites in St. Catharines for $22.0 million as well as acquired a 50% interest in 15 properties (614 suites) in Metro Vancouver for $146.25 million (half of the total acquisition price of $292.5 million). The REIT is also committed to purchase a building with 157 suites in St. Catharines, for $31.4 million, as well as two buildings with 45 suites in Vancouver, for $18.9 million, in April 2021.

Financial Highlights

Selected Consolidated Information

In $000’s, except per Unit amounts

and other non-financial data

3

Months

Ended

December

31, 2020

3

Months

Ended

December

31, 2019

Change

12

Months

Ended

December

31, 2020

12

Months

Ended

December

31, 2019

Change

Total suites

11,047

10,164

+8.7%

Average rent per suite (December)

$1,315

$1,260

+4.4%

Occupancy rate (December)

91.3%

95.6%

-430bps

Operating revenues

$41,864

$39,199

+6.8%

$159,955

 

$145,302

 

+10.1%

Net operating income (NOI)

26,365

26,206

+0.6%

102,139

96,194

+6.2%

NOI %

63.0%

66.9%

-390bps

63.9%

66.2%

-230bps

Same Property average rent per suite (December)

$1,354

$1,286

+5.3%

Same Property occupancy rate (December)

92.4%

96.7%

-430bps

Same Property NOI

22,397

23,896

-6.3%

91,313

90,664

+0.7%

Same Property NOI %

64.1%

67.4%

-330bps

64.7%

66.3%

-160bps

Net Income

$57,517

$264,975

-78.3%%

$150,648

$384,889

-60.9%

Funds from Operations (FFO)

$15,964

$15,723

+1.5%

$62,868

$56,706

+10.9%

FFO per weighted average unit – diluted

$0.112

$0.126

-11.1%

$0.466

 

$0.483

 

-3.5%

Adjusted Funds from Operations (AFFO)

$14,193

$13,938

+1.8%

$55,577

$50,303

+10.5%

AFFO per weighted average unit – diluted

$0.100

$0.111

-9.9%

$0.412

$0.428

-3.7%

Distributions per unit

$0.08008

$0.07583

+5.6%

$0.31258

$0.29334

+6.6%

Adjusted Cash Flow from Operations (ACFO)

$20,177

$19,036

+6.0%

$62,780

$61,064

+2.8%

Debt to GBV

31.1%

32.5%

-140bps

Interest coverage (rolling 12 months)

3.45x

3.12x

+0.33x

Debt service coverage (rolling 12 months)

1.95x

1.87x

+0.08x

Gross rental revenue for the year ended December 31, 2020 was $162.1 million, an increase of $18.9 million, or 13.2%, compared to 2019. Operating revenue for the year was up $14.7 million to $160.0 million, or 10.1% compared to prior year. The average monthly rent across the portfolio for December 2020 increased to $1,315 per suite from $1,260 (December 2019), an increase of 4.4%. The December 2020 vacancy rate across the entire portfolio was 8.7%, an increase from 4.4% recorded in December 2019.

On a same property portfolio basis (same properties are income properties owned by the REIT throughout the comparative periods), the average monthly rent per suite increased from $1,286 (December 2019) to $1,354 (December 2020), an increase of 5.3%. Management expects to continue to grow revenues organically through moving to market rent on suite turnovers, guideline increases, continued roll-out of AGIs, as well as continuing to drive other ancillary revenue streams.

NOI for the year ended December 31, 2020 was $102.1 million or 63.9% of operating revenue compared to $96.2 million or 66.2% of operating revenue for 2019. Costs associated with the COVID-19 pandemic represented approximately $1.9 million, or 1.2% of revenue. NOI for the quarter was $26.4 million, or 63.0% of operating revenue, compared to $26.2 million, or 66.9% of operating revenue, for the quarter ended December 31, 2019.

NOI from the same property portfolio for the year increased to $91.3 million, an increase of $0.6 million, or 0.7%, over 2019. Same property NOI margin for the year was 64.7%. Costs associated with the COVID-19 pandemic represented approximately $1.6 million. Same property NOI margin for the quarter was 64.1%. NOI from the same property portfolio decreased to $22.4 million for Q4 2020, a decrease of $1.5 million, or 6.3%, over Q4 2019. Same property NOI margin for the quarter was 64.1%.

Net income for the year was $150.6 million, a decrease of $234.2 million compared to 2019. The decrease was driven primarily by the net decrease in fair value gain on investment properties of $283.1 million ($70.1 million in 2020 compared to $353.2 million in 2019) offset by the higher non-cash fair value gains on unit-based liabilities and Class B unit liability from the Unit price depreciation in the year.

Operational Update

On March 11, 2020, the World Health Organization declared the outbreak of the novel strain of coronavirus “COVID-19” a global pandemic. The outbreak has resulted in the federal and provincial governments enacting emergency measures to combat the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods and social distancing, have caused material disruption to businesses globally resulting in an economic slowdown.

The health and safety of residents and team members remains the Trust’s top priority. InterRent REIT took quick action at the beginning of the COVID-19 crisis by introducing several new building protocols and procedures designed to ensure the wellbeing of all our communities. The Trust has also placed a high priority on maintaining strong, ongoing communication with our residents through multiple channels. The Trust recognizes that the pandemic has created significant hardship for many residents. Accordingly, the Trust is working to support residents experiencing financial difficulties through various means. The Trust has been extremely encouraged by the goodwill, positive sentiment, and community spirit that our residents have shown in the face of the pandemic and in response to the Trust’s actions.

The following information provides an operating update on the REIT’s portfolio and liquidity position:

  • InterRent REIT has collected over 99% of October, November and December residential rents and the current trend for January and February is in line with previous months.
  • Currently we have entered into rent deferral agreements with approximately 0.40% of our residential residents.
  • InterRent REIT has issued rent increases however, all increases since April had been credited as a means of helping our communities through the pandemic. Credits were reduced significantly in September and have been immaterial since that time.
  • InterRent REIT has enhanced cleaning for all of its buildings and as part of the commitment to these protocols has launched our CLV Clean & Secure+™ program (see https://www.interrentreit.com/clv-clean-and-secure-plus/ for more details).
  • InterRent REIT has developed an online information hub to provide residents and stakeholders with information regarding the pandemic as well as an online Bulletin Board for residents to communicate with each other and provide assistance to their fellow residents.
  • The REIT has continued to actively engage with residents to check on their safety and to identify residents in need of additional assistance.
  • InterRent REIT’s sales and leasing teams have implemented an end-to-end contactless rental process. Prospective residents now have the option of seeing living accommodations and completing applications online or in person.
  • The REIT had $51.6 million in cash as of December 31, 2020.
  • The REIT had no outstanding balance on any current credit facilities. The REIT has $172 million in current facilities; the ability to increase the current facilities by a further $60 million; and, an undrawn mortgage facility of $60 million, providing a total of $292 million of available credit.
  • To-date, mortgage financings and renewals have progressed on schedule with no significant delays noted as a result of COVID-19. During the fourth quarter, the REIT completed three CMHC mortgage re-financings for net proceeds of $42.0 million. Proceeds are to fund the REIT’s capital program, developments and future acquisitions.
  • With a debt to GBV ratio of 31.1%, the REIT has significant liquidity available through both CMHC insured and conventional mortgage financing to finance future capital programs, development opportunities and acquisitions.

“I am very proud of the Team we have assembled at InterRent. The commitment, compassion and energy shown by our Team members as we all had to adapt and pivot through 2020 speaks volumes about their character and our culture. The investments made in our portfolio over many years combined with a strong balance sheet provided the REIT with the ability to maintain rent levels and absorb the increased vacancy temporarily created by the pandemic while still posting good overall results for the year and positioning the REIT favorably for when immigration and student rentals resume,” said Mike McGahan, CEO

Results Conference Call

Management will host a webcast and conference call to discuss these results and current business initiatives on Monday, March 15, 2021 at 10:00 AM eastern time. The webcast will be accessible at: https://www.interrentreit.com/2020-q4-results. A replay will be available for 7 days after the webcast at the same link. The telephone numbers for the conference call are 844-539-0205 (toll free) 236-714-3164 (international). No access code required.

About InterRent

InterRent REIT is a growth-oriented real estate investment trust engaged in increasing Unitholder value and creating a growing and sustainable distribution through the acquisition and ownership of multi-residential properties.

InterRent’s strategy is to expand its portfolio primarily within markets that have exhibited stable market vacancies, sufficient suites available to attain the critical mass necessary to implement an efficient portfolio management structure and, offer opportunities for accretive acquisitions.

InterRent’s primary objectives are to use the proven industry experience of the Trustees, Management and Operational Team to: (i) to grow both funds from operations per Unit and net asset value per Unit through investments in a diversified portfolio of multi-residential properties; (ii) to provide Unitholders with sustainable and growing cash distributions, payable monthly; and (iii) to maintain a conservative payout ratio and balance sheet.

*Non-GAAP Measures

InterRent prepares and releases unaudited quarterly and audited consolidated annual financial statements prepared in accordance with IFRS (GAAP). In this and other earnings releases, as a complement to results provided in accordance with GAAP, InterRent also discloses and discusses certain non-GAAP financial measures, including Gross Rental Revenue, NOI, Same Property results, Repositioned Property results, FFO, AFFO, ACFO and EBITDA. These non-GAAP measures are further defined and discussed in the MD&A dated March 15, 2021, which should be read in conjunction with this press release. Since Gross Rental Revenue, NOI, Same Property results, Repositioned Property results, FFO, AFFO, ACFO and EBITDA are not determined by GAAP, they may not be comparable to similar measures reported by other issuers. InterRent has presented such non-GAAP measures as Management believes these measures are relevant measures of the ability of InterRent to earn and distribute cash returns to Unitholders and to evaluate InterRent’s performance. These non-GAAP measures should not be construed as alternatives to net income (loss) or cash flow from operating activities determined in accordance with GAAP as an indicator of InterRent’s performance.

Cautionary Statements

The comments and highlights herein should be read in conjunction with the most recently filed annual information form as well as our consolidated financial statements and management’s discussion and analysis for the same period. InterRent’s publicly filed information is located at www.sedar.com.

This news release contains “forward-looking statements” within the meaning applicable to Canadian securities legislation. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “anticipated”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. InterRent is subject to significant risks and uncertainties which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward looking statements contained in this release. A full description of these risk factors can be found in InterRent’s most recently publicly filed information located at www.sedar.com. InterRent cannot assure investors that actual results will be consistent with these forward looking statements and InterRent assumes no obligation to update or revise the forward looking statements contained in this release to reflect actual events or new circumstances.

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

web site: www.interrentreit.com

For further information about InterRent:

Mike McGahan

Chief Executive Officer

Tel: (613) 569-5699 Ext 244

Fax: (613) 569-5698

e-mail: [email protected]

Brad Cutsey, CFA

President

Tel: (613) 569-5699 Ext 226

Fax: (613) 569-5698

e-mail: [email protected]

Curt Millar, CPA, CA

Chief Financial Officer

Tel: (613) 569-5699 Ext 233

Fax: (613) 569-5698

e-mail: [email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Residential Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo

Cybin to Present at the M Vest and Maxim Group 2021 Emerging Growth Virtual Conference

Cybin to Present at the M Vest and Maxim Group 2021 Emerging Growth Virtual Conference

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will be presenting a business and pipeline update at the M Vest and Maxim Group 2021 Emerging Growth Virtual Conference and will participate on the psychedelics panel as follows:

Date:

Wednesday, March 17, 2021

Time:

3:30PM Eastern Time

Webcast: https://www.m-vest.com/events/2021-emerging-growth-virtual-conference

The panel discussion will be webcast live at the aforementioned time and available for 7 days thereafter using the link provided above.

About Cybin

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.

About M Vest LLC

M Vest LLC is an online investment bank and digital community built for issuers, investors, and thought leaders to share information and access investment opportunities through capital raisings of Regulation D and Regulation A Offerings. Founded in 2017 and headquartered in New York City, M-Vest provides insights on current equity market trends, hosts presentations from public companies, and provides access to capital for emerging growth companies. M-Vest hosts live conferences and webinars featuring CEOs discussing the latest developments in their industries. M Vest LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC), is a member of FINRA and SIPC, and is a sister company of Maxim Group, LLC.

About Maxim Group LLC

Maxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed-income and derivatives sales & trading, equity research and prime brokerage services. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC) and the Municipal Securities Rulemaking Board (MSRB). Member of FINRA SIPC, and NASDAQ. To learn more about Maxim Group, visit maximgrp.com

Investors:

Tim Regan/Scott Eckstein

KCSA Strategic Communications

[email protected]

Lisa M. Wilson

In-Site Communications, Inc.

[email protected]

Media:

John Kanakis

Cybin Inc.

[email protected]

Annie Graf

KCSA Strategic Communications

[email protected]

Faith Pomeroy-Ward

In-Site Communications, Inc.

[email protected]

KEYWORDS: United States North America Canada

INDUSTRY KEYWORDS: Biotechnology Health Other Health

MEDIA:

Logo
Logo

Industry First, Nickel 28 Buys Carbon Offsets for Its Share of Ramu Nickel and Cobalt Production

Industry First, Nickel 28 Buys Carbon Offsets for Its Share of Ramu Nickel and Cobalt Production

TORONTO–(BUSINESS WIRE)–
Nickel 28 Capital Corp. (“Nickel 28” or the “Company”) (TSXV: NKL) (FSE: 3JC), one of Canada’s only pure-play nickel and cobalt producers, is pleased to provide the following update.

  • Nickel 28 has purchased 52,500 carbon offsets on the Verra Registry
  • The carbon offsets will fully offset Nickel 28’s anticipated 2021 attributable greenhouse gas (GHG) emissions from the Ramu integrated nickel-cobalt mine and refinery
  • The Company believes this will make it the mining industry’s first carbon neutral refined nickel-cobalt producer

Anthony Milewski, the Company’s Chairman, commented “We are incredibly excited to be one of the first, if not the first, producers of refined nickel and cobalt in the world to fully offset its carbon footprint. We feel strongly that each of us has an obligation to do our part personally and professionally to help stave off the negative impacts of climate change. As the world pivots to electric vehicles and other means of decarbonization, it is imperative that the critical basic materials fueling the transition have the minimum possible impact on the environment.”

On February 9, 2021, the Company announced that it had completed an independent analysis on GHG intensity for the Ramu nickel-cobalt operation, confirming the operation is one of the lower GHG emitters in the nickel industry. Ramu’s average GHG intensity has been calculated at 15.6 tonnes carbon dioxide equivalent per tonne of nickel (15.6 tCO2e/t Ni) in mixed hydroxide product. This compares favourably to a nickel industry average GHG intensity of 36.6 tCO2e/t Ni as calculated by Wood Mackenzie.

Nickel 28 will continue to introduce greater ESG (environmental, social and governance) transparency with respect to its assets in response to investor and industry trends. In addition to GHG emission reporting, Nickel 28 will be providing further clarity with respect to other key measures such as health and safety statistics, community investment, energy and water usage, rehabilitation, and land reclamation.

About Nickel 28

Nickel 28 Capital Corp. is a nickel-cobalt producer through its 8.56% joint-venture interest in the producing, long-life and world-class Ramu Nickel-Cobalt Operation located in Papua New Guinea. Ramu provides Nickel 28 with significant attributable nickel and cobalt production thereby offering our shareholders direct exposure to two metals which are critical to the adoption of electric vehicles. In addition, Nickel 28 manages a portfolio of 13 nickel and cobalt royalties on development and exploration projects in Canada, Australia and Papua New Guinea.

Cautionary Note Regarding Forward-Looking Statements

This news release contains certain information which constitutes ‘forward-looking statements’ and ‘forward-looking information’ within the meaning of applicable Canadian securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to: statements and figures with respect to the operational and financial results; statements with respect to the Company’s GHG emissions, statements with respect to the prospects of nickel and cobalt in the global electrification of vehicles; statements related to the repayment of the Company Ramu operating debt; and statements with respect to the business and assets of Nickel 28 and its strategy going forward. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, most of which are beyond the Company’s control. Should one or more of the risks or uncertainties underlying these forward-looking statements materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance or achievements could vary materially from those expressed or implied by the forward-looking statements.

The forward-looking statements contained herein are made as of the date of this release and, other than as required by applicable securities laws, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. The forward-looking statements contained in this release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No securities regulatory authority has either approved or disapproved of the contents of this news release.

Investor:

Justin Cochrane

Tel: 647.846.7765

Email: [email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Natural Resources Manufacturing Other Manufacturing Environment Mining/Minerals

MEDIA:

Logo
Logo

Hatch LTK celebrates 100th anniversary

Philadelphia, PA, March 15, 2021 (GLOBE NEWSWIRE) — Hatch LTK, a global powerhouse in transportation engineering with specialized expertise in transit, vehicles, and systems, will celebrate its 100th anniversary on Monday, March 15.

The company was founded in Philadelphia, PA in 1921 by Louis Tobias Klauder, who was the sole employee at the time. Over the years, the firm grew to more than 450 employees in 23 offices spread over four countries, including China and Australia. In November of 2020, LTK merged with Hatch, a global engineering, project management, and professional services firm with 9,000-plus employees in the mining, infrastructure, and energy sectors.

Hatch LTK’s centennial commemoration will continue throughout 2021 as the company highlights key moments in its history, hosts events for employees and clients, and conducts community service projects.

“As we celebrate the firm’s 100th anniversary, we look back with pride at our substantial accomplishments,” said Dominic DiBrito, Hatch’s managing director, Infrastructure, USA. “We have connected communities, which has allowed individuals to commute to better jobs. We have helped transform urban design by developing crucial transit corridors. And, we’ve played a significant role in reducing climate change by helping to provide more efficient transportation options.

“Through all of this, we have remained close to the communities we serve, giving back by volunteering, and supporting local philanthropic causes. Now, having joined the Hatch family, we look forward with great anticipation to the next 100 years. Together, there is nothing we can’t achieve.”

John Bianchini, Hatch’s chairman and CEO added: “As we reflect on Hatch LTK’s 100 years and the impacts that we’ve created during that time, we’re inspired to continue to build on that legacy to create unprecedented outcomes for our clients by partnering with them to develop better ideas for many years to come. Combining the LTK transit team with Hatch’s global multidisciplinary staff with broad design and construction experience in freight rail, transit, and port infrastructure yields a premier service offering to all of our clients. Together, we’ll continue tackling the toughest challenges facing our communities now and into the future.”

About Hatch

Whatever our clients envision, our engineers can design and build. With over six decades of business and technical experience in the mining, energy, and infrastructure sectors, and corporate roots extending back over 100 years, we know your business and understand that your challenges are changing rapidly. We respond quickly with solutions that are smarter, more efficient and innovative. We draw upon our 9,000 staff with experience in over 150 countries to challenge the status quo and create positive change for our clients, our employees, and the communities we serve.

Find out more on www.hatch.com.

Attachments



Lindsay Janca
Hatch Ltd
9054034199
[email protected]

Uplifting Children’s Book Teaches Readers to Embrace Being Unique

Author and Preschool Leader Suzanne Anderson educates kids to accept everyone for who they are in new book, ‘The Story of the Plain Brown Wren’

ARGYLE, Texas, March 15, 2021 (GLOBE NEWSWIRE) — God gives every individual gifts and talents that make one unique. In first-time author Suzanne Anderson’s book, “The Story of the Plain Brown Wren,” readers will recognize and honor the importance of being different and treating everyone equally. The tale follows a young wren and her birdie friends as they embark on an unexpected journey.

The book’s beginning showcases Wren being mocked by her friends for not being as extraordinary as they are. As their play area gets too hot, they go on an expedition to find a cooler place to play but get lost within a dark cave and have to figure out a way to break free. Throughout their dilemma, Anderson illustrates how even though Wren had different characteristics and traits from her fellow birdie friends, she is just as astonishing as they are. With the help of Bible verses, readers will learn valuable lessons about equality and friendship.

“’The Story of the Plain Brown Wren’ is the first book out of an eight-book series,” said Anderson. “My goal is to bring back childhood stories told in creative and interesting ways that become lifelong memories and pertinent teaching tools.”

By the end of the book, Wren helps her friends acknowledge how they should recognize and honor the unique traits they each possess by bringing them to safety. With the help of Brother Eagle, Anderson beautifully peppers in the importance of God’s Word that is taught within Wren’s story. Ultimately, “The Story of the Plain Brown Wren” will teach readers that being unique is a gift from God and is meant to guide individuals to a life of loving others.

“The Story of the Plain Brown Wren”
By Suzanne Anderson
ISBN: 978-1-4897-3051-0 (softcover); 978-1-4897-3077-0 (hardcover); 978-1-4897-3050-3 (eBook)
Available at LifeRich Publishing, Amazon and Barnes & Noble

About the author
Suzanne Anderson is a successful entrepreneur and a newly published author. Her books are dedicated to meaningful stories that will teach children important life lessons. She founded The Nest Christian Academy, an academically strong kindergarten prep school in Argyle, Texas, where she currently serves as director and ministry leader. It is her fervent prayer that the children’s stories of her past become important reading material for children now. Anderson is a grandmother and preschool leader; she has taken her lifelong success in business and applied it to the Christian education environment today, hoping to add lost stories from another era to the resources needed to educate young children. “The Story of the Plain Brown Wren” is the first book out of an eight-book series. Each book is an integral part of the exemplary curriculum of The Nest Christian Academy. To learn more information, please visit https://www.theneststorybooks.com/.

LifeRich Publishing, the strategic publishing partnership of Reader’s Digest and Author Solutions, LLC, was created to provide all writers a platform for sharing their stories, recipes, advice and more. LifeRich authors will benefit from a wealth of editorial design, marketing and education resources, specially created by Reader’s Digest editors for the enrichment of these LifeSmart individuals. Books can be published in print, ebook or audio formats, with additional distribution to up to 25 million Reader’s Digest customers through its online properties. For more information or to publish a book, please visit liferichpublishing.com or call 1-888-238-8637.

 

Attachment



Grace Bywater
LAVIDGE
480-998-2600 X 534
[email protected]

MATEON ANNOUNCES INITIATION OF PHASE 1B CLINICAL TRIAL ON OT-101/IL-2 COMBINATION THERAPY FOR SOLID TUMORS

AGOURA HILLS, California, March 15, 2021 (GLOBE NEWSWIRE) — Mateon Therapeutics Inc. (OTCQB:MATN) today announced the regulatory approval from the Ministry of Food and Drug Safety of Korea for the phase 1b clinical trial of a patented OT-101/IL-2 combination. This phase 1b clinical trial will confirm the safety and effectiveness of OT-101/IL-2 in solid cancer patients in cooperation with the UK global pharmaceutical company Clinigen Group. The study will be conducted together with Autotelic BIO- a partner of Mateon on OT-101/IL-2 combination.

OT-101 has received orphan drug designation for glioblastoma, melanoma, and pancreatic cancer. Furthermore, FDA recently granted Rare Pediatric Designation for OT-101 against diffuse intrinsic pontine glioma (DIPG). OT-101 is also effective against coronavirus including COVID-19 and being deployed against the COVID-19 epidemic.

OT-101 has demonstrated robust efficacy against pancreatic cancer, glioblastoma, and melanoma during phase 2 clinical trials. The demonstration that OT-101 will synergize with IL-2 further demonstrate its utility as adjunct to other immunotherapies. Interleukin-2 (IL-2, Aldesleukin, PROLEUKIN®) Immunotherapy is cancer treatment that stimulates the body’s immune system to fight cancer, such as melanoma.

About Mateon Therapeutics

Mateon was created by the recent reverse merger with Oncotelic which became a wholly owned subsidiary of Mateon Therapeutics Inc. creating an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer. OT-101, the lead immune-oncology drug candidate of Mateon/Oncotelic, is a first-in-class RNA therapeutic targeting TGF beta that exhibited single agent activity in some relapsed/refractory cancer patients in clinical trial settings. The founding team members of Oncotelic were responsible for the development of Abraxane as chemotherapeutic agents for breast, lung, melanoma, and pancreatic cancer. Abraxane was approved in 2005 and has more than $1B in sales annually. The same founding team was responsible for the development of Cynviloq, a next generation Abraxane, which was acquired by NantPharma for $1.3B. Mateon/Oncotelic will leverage its deep expertise in oncology and RNA therapeutic drug development to improve treatment outcomes and survival of cancer patients. For more information, please visit www.oncotelic.com and www.mateon.com.

About OT-101

OT-101 is an antisense against the host TGF-β protein required for viral replication and its overexpression likely to cause the wide range of clinical symptoms associated with COVID-19 including Kawasaki syndrome (Fatih M. Uckun, Vuong Trieu. Targeting Transforming Growth Factor-beta for Treatment of COVID-19-associated Kawasaki Disease in Children. Clin Res Pediatr 2020; 3(1): 1-3) and acute respiratory distress syndrome (ARDS) (Fatih M. Uckun, Larn Hwang, Vuong Trieu. Selectively targeting TGF-β with Trabedersen/OT-101 in treatment of evolving and mild ARDS in COVID-19. Clin. Invest. (Lond.) 2020; 10(2), 167-176. DOI: 10.4172/ Clinical-Investigation.1000166.).

TGF-β is elevated in COVID-19 (Xiong Y. et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerging Microbes & infections 2020; 9:1, 761-770, DOI: 10.1080/22221751.2020.1747363. Agrati C. et al. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death & Differentiation 2020; https://doi.org/10.1038/s41418-020-0572-6.).

About Mateon Therapeutics

Mateon was created by the 2019 merger with Oncotelic, which became a wholly owned subsidiary of Mateon, thereby creating an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of Mateon/Oncotelic, is a first-in-class anti-TGF-βRNA therapeutic that exhibited single agent activity in some relapsed/refractory cancer patients in clinical trial settings. OT-101 also has activity against SARS-CoV-2. Mateon/Oncotelic is seeking to leverage its deep expertise in oncology drug development to improve treatment outcomes and survival of cancer patients with a special emphasis on rare paediatric cancers. Mateon has rare paediatric designation for DIPG (OT-101), melanoma (CA4P), and AML (OXi4503). For more information, please visit www.oncotelic.com and www.mateon.com.

Mateon’s Cautionary Note on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this communication regarding strategy, future operations, future financial position, prospects, plans and objectives of management are forward-looking statements. Words such as “may”, “expect”, “anticipate” “hope”, “vision”, “optimism”, “design”, “exciting”, “promising”, “will”, “conviction”, “estimate,” “intend,” “believe”, “quest for a cure of cancer”, “innovation-driven”, “paradigm-shift”, “high scientific merit”, “impact potential” and similar expressions are intended to identify forward-looking statements. Forward-looking statements contained in this press release include, but are not limited to, statements about future plans, the progress, timing, clinical development, scope and success of future clinical trials, the reporting of clinical data for the company’s product candidates and the potential use of the company’s product candidates to treat various cancer indications. Each of these forward-looking statements involves risks and uncertainties and actual results may differ materially from these forward-looking statements. Many factors may cause differences between current expectations and actual results, including unexpected safety or efficacy data observed during preclinical or clinical studies, clinical trial site activation or enrollment rates that are lower than expected, changes in expected or existing competition, changes in the regulatory environment, failure of collaborators to support or advance collaborations or product candidates and unexpected litigation or other disputes. These risks are not exhaustive, the company faces known and unknown risks, including the risk factors described in the company’s annual report on Form 10-K filed with the SEC on April 10, 2019 and in the company’s other periodic filings. Forward-looking statements are based on expectations and assumptions as of the date of this press release. Except as required by law, the company does not assume any obligation to update forward-looking statements contained herein to reflect any change in expectations, whether as a result of new information future events, or otherwise.

Contact Information:

For Mateon Therapeutics, Inc.:
Amit Shah
[email protected]



VSBLTY, GRUPO MODELO & RETAILIGENT FORMALIZE AGREEMENT TO JOINTLY CREATE INTERNATIONAL DIGITAL IN-STORE MEDIA NETWORK

Network to Provide Real Time Customer Analytics, Security & Sensor Integration in Up to 50,000 Modelorama Stores & Independent Neighborhood Bodegas in Latin America

Philadelphia, PA, March 15, 2021 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF) (“VSBLTY”), a leading software provider of security and retail analytics technology, along with Mexico’s Grupo Modelo (“Modelo”) (part of the AB InBev family of companies) and Retailigent Media have formalized an agreement (the “Agreement”) to enter into a joint venture by the end of Q2 to install and manage an international in-store media network of up to 50,000 Modelorama stores and independent neighborhood bodegasin Mexico and across Latin America by the end of 2024, it was announced today. Active deploymentis already underway in Mexico, Colombia, Peru, and Ecuador with 5000 locations to be installed by the end of 2021.

In addition to being an international advertising network, it will provide real-time security for store owners, powered by artificial intelligence, as well as integration of store traffic and customer demographics with sales and critical operations-related data to help stores optimize their business.

VSBLTY Co-founder & CEO Jay Hutton said, “The deployments are already underway in Mexico, Colombia, Peru, and Ecuador and we have started contracting media time to consumer-packaged goods brands to advertise to Latin American shoppers right at point-of-sale where buying decisions are made. VSBLTY will be supplying its proprietary software for analytics, security, and visual display,” Hutton said. “The three firms will be equal partners in the joint venture. VSBLTY will earn revenue from the joint venture in two ways. First, and more modestly, from the licensing fees to VSBLTY for the proprietary software that will be leveraged by the joint venture, and second, and most significantly, VSBLTY will share in one-third of the annual operating profits from advertising revenue, modeled to be greater than $200MM USD in total to the joint venture over the first five years,” he concluded.

AB InBev is the world’s largest brewer with a diverse portfolio of more than 500 brands, including iconic global beers Budweiser, Corona, and Stella Artois. Part of AB InBev, Grupo Modelo is the leader in the production, distribution, and sale of beer in Mexico and owns and operates Modelorama, Mexico’s second largest convenience store chain.

Pedro Garavito, Vice President of Technology & Transformation, Middle Americas, said, “By leveraging technology and analytics we can play a pivotal role in the communities we serve by improving the safety and quality of the shopping experience for the millions of store owners with whom we do business every day. Not only can the various solutions around Internet of Things (IoT) offer real time access to point-of-sale systems to allow store owners to dynamically optimize their business, but we can also incorporate security, consumer analytics and display advertising under the same platform. At the same time, we will be enabling local store owners and operators to remain competitive as retail consolidates in most Latin American markets. The innovation and agility provided by VSBLTY and Retailigent Media, when coupled with our reach, will allow us to have a meaningful and positive impact on the retail industry in Central and South America.” 

Thiago Porto, VP of Transformation and People, Middle Americas, said, “This exciting plan of action—with a target of a 50,000-store deployment by 2024— will enable traditional neighborhood stores, the most important channel for consumer products in Latin America, to keep pace as the retail industry goes through monumental digital transformation.”

Retailigent Media, with offices in Mexico and five other Latin American countries, is the leading company in Mexico for smart retail solutions, analytics, and smart displays. Retailigent provides advertising and marketing insights to some of the world’s leading brands, including P&G, Coca-Cola, Diageo, and Telefonica. “We have a long-standing working relationship with VSBLTY and we are partnering with RADAR App to support in-store security in each of the stores we plan to develop throughout Latin America. Radar App is the first collaborative security solution in the world that is already being utilized in Mexico City counties. Now we will be working together to help Grupo Modelo create a new revenue stream for their stores, improve security, and become an attractive media channel as well,” according to Rodrigo Velasco, Retailigent Media CEO & Co-founder.

In connection with entering into the Agreement, VSBLTY has agreed to issue to Modelo 15,500,000 common share purchase warrants of VSBLTY (the “Warrants”). Each Warrant will be exercisable to acquire one common share of VSBLTY for a period of five (5) years from the date of issuance at an exercise price of at CAD $0.84 per share, subject to the following vesting conditions: 

(a) 15% of the Warrants will vest immediately as a result of execution of the Agreement;

(b) 15% of the Warrants will vest upon execution of the definitive agreements for the joint venture;

(c) 20% of the Warrants will vest upon the joint venture having been installed and operating in at least 1,500 locations;

(d) 20% of the Warrants will vest upon the joint venture having been installed and operating in at least 5,000 locations;

(e) 15% of the Warrants will vest upon the joint venture having been installed and operating in at least 20,000 locations; and

(f) 15% of the Warrants will vest upon the joint venture having been installed and operating in at least 30,000 locations.

In addition, VSBLTY will issue to Modelo 2,500,000 additional Warrants upon the joint venture having been installed and operating in at least 1,500 locations and a further 2,500,000 additional Warrants upon the joint venture having been installed and operating in at least 5,000 locations (collectively, the “Additional Warrants”). The Additional Warrants will have an exercise price equal to the closing price of VSBLTY’s common shares on the last trading prior to reaching the 1,500 locations milestone and will be exercisable for a period of five (5) years from the date of issuance.

VSBLTY technology provides enhanced customer engagement and audience measurement including store traffic and customer demographics. Its industry-leading VisionCaptor™ and DataCaptor™ software combine motion graphics and interactive brand messaging with cutting-edge computer vision measurement and insights. VSBLTY’s AI-driven software, Vector™ provides advanced facial recognition that is crucial to enhancing security in a variety of environments. 

 

Investor Relations

CHF Capital Markets

Cathy Hume, CEO, +1-416-868-1079, x231

[email protected]

CONTACT: Linda Rosanio, 609-472-0877 

[email protected]

About VSBLTY (

www.vsblty.net

)

Headquartered in Philadelphia, VSBLTY (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF) (“VSBLTY”) is the world leader in Proactive Digital Display™, which transforms retail and public spaces as well as place-based media networks with SaaS-based audience measurement and security software that uses artificial intelligence and machine learning.

About Grupo Modelo (www.gmodelo.mx)

Founded in 1925, Grupo Modelo is the leader in the production, distribution, and sale of beer in Mexico and since 2013 part of the world’s largest brewing group, Anheuser-Busch InBev. The firm has 17 national brands, including Corona, and imports seven additional brands. Grupo Modelo operates 10 breweries in Mexico and has more than 32,000 employees.

CONTACT: Fernando Morales, +52 55 5174 9000 x55067

[email protected]

About Retailigent Media (www.retailigentmedia.com)

VSBLTY partners with Retailigent Media that has been a pioneer throughout Latin 
America in making smart deployments at retail with digital displays and analytics. Retailigent Media also provides OOH traffic measurements and predictive advertising triggered by gender and age. The firm is helping retailers and cities improve their security with VSBLTY’s Vector Face Recognition and Alerts.

CONTACT: Rodrigo Velasco, +52 1 55 9196 7427  

[email protected]

 

FORWARD-LOOKING STATEMENT

Certain statements in this news release constitute forward-looking information within the meaning of applicable securities laws. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “expects,” “believes,” “anticipates,” “budget, “scheduled,” “estimates,” “forecasts,” “intends,” “plans,” and variations of such words and phrases, or by statements that certain actions, events or results “may,” “will,” “could,” “would,” or “might,” “be taken,” “occur,” or “be achieved.” Those forward- looking statements include a number of statements related to the outlook for future operations, including statements about VSBLTY’s proposed joint venture with Modelo and Retailigent Media, business plans, booking new projects, revenue growth, and new opportunities presented by VSBLTY.

Forward-looking statements are neither historical facts nor assurances of future performance. Forward-looking information contained in this news release is based on certain assumptions regarding, among other things, expected growth, results of operations, performance, industry trends and growth opportunities. While management considers these assumptions to be reasonable, based on information available, they may prove to be incorrect. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and other factors include, but are not limited to: pricing for the Company’s products and services; the ability to enter into contracts and ability of third parties to honor their contractual obligations; the decisions of third parties over which the Company has no control; changes to government regulations; force majeure events; limits on the ability of the Company to implement and fulfill its business strategies; general economic conditions; adverse industry events; operating costs exceeding the Company’s expectations; loss of markets or failure to enter new markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the ability of the Company to implement its business strategies including expansion plans; and competition. The foregoing factors are not intended to be exhaustive, and readers should refer to the detailed risk factors described in VSBLTY’s Annual Information Form which is available under the Company’s profile at www.sedar.com. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this news release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. 

This news release includes financial outlook, specifically projected net income from the Company’s proposed joint venture with Modelo and Retailigent Media, which is subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraphs. In addition, the Company’s net income projections are based on other factors, including the following key assumptions: (i) the joint venture’s ability to successfully develop and deploy its products; (ii) the joint venture’s pricing targets remaining in place; (iii) the Company’s ability to maintain performance and quality as the joint venture advances and product volume increases, (iv) 70% of advertising inventory sold, and (v) extension of the joint venture to 5,000 locations by end of 2021, 5,000 locations by end of 2022, 35,000 locations by end of 2023 and 55,000 locations by end of 2024. Accordingly, the financial projections are only estimates and are necessarily speculative in nature. It is expected that some – and perhaps all – of the assumptions in the financial projections will not be realized and that actual results will vary from the projections. Such variations may be material and may increase over time. Such financial projections contained in this news release were made by management as of the date of this news release and are provided for the purpose of providing readers with an understanding of the Company’s business plan and significance of the Company’s proposed joint venture. Readers are cautioned that the financial outlook contained in this document should not be used for purposes other than for which it is disclosed herein.

 

 

 

 



LINDA ROSANIO
VSBLTY, INC
609-472-0877
[email protected]